NEJM This Week — February 17, 2022 - a podcast by The New England Journal of Medicine

Featuring articles on LentiGlobin for sickle cell disease, tisagenlecleucel in aggressive B-cell lymphoma, axi-cel for relapsed or refractory large B-cell lymphoma, and EDP-938 to treat respiratory syncytial virus; a review article on electroconvulsive therapy; a case report of a woman with rapidly progressive weakness in the right arm and recurrent falls; and Perspective articles on health care safety during the pandemic and beyond, on inherited patients taking opioids for chronic pain, and on home help.

Further episodes of NEJM This Week

Further podcasts by The New England Journal of Medicine

Website of The New England Journal of Medicine